| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 34.030 | 22.468 | - | 41.009 | 63.137 | 35.345 | 94.310 | 126.430 | 112.162 | 72.880 |
| Total Income - EUR | 34.034 | 22.675 | - | 41.026 | 63.137 | 36.689 | 96.117 | 126.430 | 131.498 | 72.887 |
| Total Expenses - EUR | 31.190 | 22.296 | - | 39.744 | 44.241 | 34.509 | 86.650 | 86.505 | 96.004 | 88.916 |
| Gross Profit/Loss - EUR | 2.845 | 379 | - | 1.282 | 18.895 | 2.180 | 9.467 | 39.925 | 35.494 | -16.030 |
| Net Profit/Loss - EUR | 1.824 | 233 | - | 872 | 18.250 | 1.847 | 8.525 | 38.813 | 34.161 | -17.874 |
| Employees | 3 | 3 | - | 3 | 2 | 3 | 4 | 5 | 6 | 5 |
Check the financial reports for the company - Policlinica Promed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 44.501 | 49.834 | - | 51.885 | 43.700 | 61.264 | 56.765 | 42.540 | 54.315 | 47.381 |
| Current Assets | 30.585 | 50.764 | - | 56.980 | 46.666 | 52.198 | 51.560 | 55.429 | 58.096 | 11.683 |
| Inventories | 16.964 | 24.741 | - | 33.811 | 31.496 | 35.092 | 17.963 | 6.545 | 6.468 | 205 |
| Receivables | 11.354 | 20.835 | - | 20.135 | 12.032 | 14.481 | 31.123 | 43.376 | 48.626 | 3.361 |
| Cash | 2.267 | 5.188 | - | 3.034 | 3.138 | 2.625 | 2.474 | 5.507 | 3.002 | 8.117 |
| Shareholders Funds | 6.454 | 6.621 | - | 7.429 | 25.534 | 26.898 | 15.129 | 53.988 | 65.306 | 38.286 |
| Social Capital | 225 | 223 | - | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 68.632 | 93.977 | - | 101.436 | 64.832 | 86.564 | 6.472 | 43.980 | 47.104 | 20.778 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Policlinica Promed S.r.l.